1.60
price up icon2.56%   0.04
after-market アフターアワーズ: 1.60
loading
前日終値:
$1.56
開ける:
$1.53
24時間の取引高:
63,867
Relative Volume:
0.90
時価総額:
$90.68M
収益:
-
当期純損益:
$-46.12M
株価収益率:
-2.1425
EPS:
-0.7468
ネットキャッシュフロー:
$-41.02M
1週間 パフォーマンス:
+2.24%
1か月 パフォーマンス:
+2.56%
6か月 パフォーマンス:
+15.94%
1年 パフォーマンス:
+15.94%
1日の値動き範囲:
Value
$1.52
$1.60
1週間の範囲:
Value
$1.49
$1.60
52週間の値動き範囲:
Value
$1.14
$2.10

Inflarx N V Stock (IFRX) Company Profile

Name
名前
Inflarx N V
Name
セクター
Healthcare (1182)
Name
電話
-
Name
住所
-
Name
職員
66
Name
Twitter
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
IFRX's Discussions on Twitter

Inflarx N V Stock (IFRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-04-05 アップグレード Guggenheim Neutral → Buy
2022-02-28 ダウングレード Guggenheim Buy → Neutral
2021-10-28 アップグレード Raymond James Outperform → Strong Buy
2021-03-11 アップグレード Guggenheim Neutral → Buy
2020-11-06 アップグレード SVB Leerink Mkt Perform → Outperform
2020-10-08 開始されました H.C. Wainwright Buy
2020-06-17 開始されました BTIG Research Buy
2020-04-30 アップグレード Raymond James Mkt Perform → Outperform
2019-06-05 ダウングレード BMO Capital Markets Outperform → Market Perform
2019-06-05 ダウングレード Guggenheim Buy → Neutral
2019-06-05 ダウングレード JP Morgan Overweight → Underweight
2019-06-05 ダウングレード Robert W. Baird Outperform → Neutral
2019-06-05 ダウングレード SunTrust Buy → Hold
2019-01-29 開始されました Robert W. Baird Outperform
2018-12-10 開始されました Credit Suisse Outperform
2018-07-13 開始されました BMO Capital Markets Outperform
2018-06-28 開始されました Raymond James Outperform
2018-06-28 開始されました SunTrust Buy
2018-02-08 開始されました B. Riley FBR, Inc. Buy
すべてを表示

Inflarx N V (IFRX) 最新ニュース

pulisher
Nov 01, 2024

InflaRx (IFRX) Set to Announce Quarterly Earnings on Friday - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

InflaRx to Report Third Quarter 2024 Financial Results on - GlobeNewswire

Oct 31, 2024
pulisher
Oct 14, 2024

InflaRx (NASDAQ:IFRX) Sees Significant Increase in Short Interest - MarketBeat

Oct 14, 2024
pulisher
Sep 26, 2024

InflaRx shares maintain Buy rating from H.C. Wainwright on Gohibic trial analysis - Investing.com

Sep 26, 2024
pulisher
Sep 25, 2024

InflaRx (NASDAQ:IFRX) Given Buy Rating at HC Wainwright - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx reports promising HS treatment results at EADV Congress - Investing.com India

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx (NASDAQ:IFRX) Given "Buy" Rating at HC Wainwright - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx presents e-poster presentation of post hoc analysis of SHINE study - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx Presents Post Hoc Analysis of SHINE Trial of - GlobeNewswire

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 - EIN News

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx reports promising HS treatment results at EADV Congress By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 05, 2024

InflaRx Announces Participation in September Investor Events - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 05, 2024

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 04, 2024

InflaRx (NASDAQ:IFRX) Stock Price Up 1.3% - MarketBeat

Sep 04, 2024
pulisher
Sep 04, 2024

InflaRx (NASDAQ:IFRX) Shares Up 1.3% - Defense World

Sep 04, 2024
pulisher
Sep 03, 2024

InflaRx reports promising data on oral C5aR inhibitor INF904 - Investing.com

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human - EIN News

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx reports promising data on oral C5aR inhibitor INF904 By Investing.com - Investing.com UK

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx presents new preclinical findings for INF904 - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx Presents New Preclinical Findings for INF904 at the - GlobeNewswire

Sep 03, 2024
pulisher
Sep 01, 2024

InflaRx (NASDAQ:IFRX) Short Interest Down 9.2% in August - MarketBeat

Sep 01, 2024
pulisher
Aug 13, 2024

Short Interest in InflaRx (NASDAQ:IFRX) Rises By 281.4% - MarketBeat

Aug 13, 2024
pulisher
Aug 08, 2024

InflaRx N.V. (IFRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 08, 2024
pulisher
Aug 08, 2024

InflaRx N.V. Reports Mid-Year Financial Results - TipRanks

Aug 08, 2024
pulisher
Aug 08, 2024

InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Aug 08, 2024
pulisher
Aug 08, 2024

InflaRx reports Q2 EPS (24c), consensus (22c) - TipRanks

Aug 08, 2024
pulisher
Aug 07, 2024

InflaRx (IFRX) Set to Announce Earnings on Thursday - Defense World

Aug 07, 2024
pulisher
Aug 02, 2024

InflaRx (IFRX) to Release Earnings on Thursday - MarketBeat

Aug 02, 2024
pulisher
Aug 01, 2024

InflaRx to Report Second Quarter 2024 Results on August 8, 2024 - GlobeNewswire

Aug 01, 2024
pulisher
Jul 30, 2024

InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases - GlobeNewswire

Jul 30, 2024
pulisher
Jul 15, 2024

Vasculitis Treatment Market with Tremendous growth by 2031 – Glaxosmithkline plc, Amneal Pharmaceuticals, Inc., ChemoCentryx, InflaRx N.V – TIMC - TIMC

Jul 15, 2024
pulisher
Jul 14, 2024

InflaRx (NASDAQ:IFRX) Short Interest Up 151.1% in June - American Banking and Market News

Jul 14, 2024
pulisher
Jul 12, 2024

Short Interest in InflaRx (NASDAQ:IFRX) Expands By 151.1% - MarketBeat

Jul 12, 2024
pulisher
Jul 12, 2024

Short Interest in InflaRx (NASDAQ:IFRX) Rises By 151.1% - Defense World

Jul 12, 2024
pulisher
Jun 28, 2024

InflaRx Announces $75M Share Sales Agreement - TipRanks

Jun 28, 2024
pulisher
Jun 28, 2024

InflaRx N.V. (IFRX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia

Jun 28, 2024
pulisher
Jun 28, 2024

InflaRx (NASDAQ:IFRX) Short Interest Update - MarketBeat

Jun 28, 2024
pulisher
Jun 27, 2024

What Kind Of Investors Own Most Of InflaRx N.V. (NASDAQ:IFRX)? - Yahoo New Zealand News

Jun 27, 2024
pulisher
Jun 26, 2024

SEC Form 424B5 filed by InflaRx N.V. - Quantisnow

Jun 26, 2024
pulisher
Jun 25, 2024

InflaRx (NASDAQ:IFRX) Receives “Buy” Rating from HC Wainwright - Defense World

Jun 25, 2024
pulisher
Jun 24, 2024

InflaRx's ARDS drug selected for BARDA Phase 2 study - Investing.com India

Jun 24, 2024
pulisher
Jun 24, 2024

Cathie Wood's ARK ETF focuses on PagerDuty, 10X Genomics stock By Investing.com - Investing.com

Jun 24, 2024
pulisher
Jun 24, 2024

Iron Mountain executive sells over $547k in company stock By Investing.com - Investing.com UK

Jun 24, 2024
pulisher
Jun 24, 2024

InflaRx's GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed ... - WICZ

Jun 24, 2024
pulisher
Jun 24, 2024

InflaRx's GOHIBIC (Vilobelimab) Selected for First - GlobeNewswire

Jun 24, 2024
pulisher
Jun 24, 2024

InflaRx’s GOHIBIC (Vilobelimab) Selected for First - GlobeNewswire

Jun 24, 2024
pulisher
Jun 07, 2024

InflaRx's (IFRX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jun 07, 2024
pulisher
Jun 06, 2024

InflaRx's (IFRX) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Jun 06, 2024
pulisher
Jun 05, 2024

InflaRx Hosts R&D Event Highlighting the Promise of INF904 - GlobeNewswire

Jun 05, 2024
pulisher
Jun 03, 2024

InflaRx (NASDAQ:IFRX) Trading Up 10.5% - MarketBeat

Jun 03, 2024

Inflarx N V (IFRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):